Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: Impact of patient selection factors on outcome Academic Article uri icon

Overview

MeSH Major

  • Lymph Node Excision
  • Neoplasms, Germ Cell and Embryonal
  • Patient Selection
  • Testicular Neoplasms

abstract

  • Excluding patients with CS IIB disease or elevated postorchiectomy STM from primary RPLND has had a favorable impact on the extent of retroperitoneal disease and has significantly reduced the risk of relapse after RPLND. For patients with normal STM and CS I to IIA disease, the low rate of systemic progression and 22% incidence of retroperitoneal teratoma supports RPLND as the preferred primary intervention.

publication date

  • April 20, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.07.132

PubMed ID

  • 15837993

Additional Document Info

start page

  • 2781

end page

  • 8

volume

  • 23

number

  • 12